In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond

Advanced Drug Delivery Reviews
Ni AiSean Ekins

Abstract

Drug-drug interactions (DDIs) are associated with severe adverse effects that may lead to the patient requiring alternative therapeutics and could ultimately lead to drug withdrawal from the market if they are severe. To prevent the occurrence of DDI in the clinic, experimental systems to evaluate drug interaction have been integrated into the various stages of the drug discovery and development process. A large body of knowledge about DDI has also accumulated through these studies and pharmacovigillence systems. Much of this work to date has focused on the drug metabolizing enzymes such as cytochrome P-450s as well as drug transporters, ion channels and occasionally other proteins. This combined knowledge provides a foundation for a hypothesis-driven in silico approach, using either cheminformatics or physiologically based pharmacokinetics (PK) modeling methods to assess DDI potential. Here we review recent advances in these approaches with emphasis on hypothesis-driven mechanistic models for important protein targets involved in PK-based DDI. Recent efforts with other informatics approaches to detect DDI are highlighted. Besides DDI, we also briefly introduce drug interactions with other substances, such as Traditional Chines...Continue Reading

References

Apr 1, 1987·Journal of Cardiovascular Pharmacology·G SantostasiS Dalla-Volta
Oct 25, 1982·Journal of Molecular Biology·I D KuntzT E Ferrin
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jul 24, 2001·Current Drug Metabolism·S A Sheweita
Aug 8, 2001·Journal of Pharmacological and Toxicological Methods·S Ekins, S A Wrighton
Dec 18, 2001·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sean Ekins, Jon A Erickson
Mar 30, 2002·Advanced Drug Delivery Reviews·Marcel J de Groot, Sean Ekins
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sean EkinsSteven A Wrighton
Apr 19, 2002·Molecular Pharmacology·Sean EkinsSteven A Wrighton
Dec 14, 2002·Journal of Molecular Graphics & Modelling·C M VenkatachalamM Waldman
Mar 4, 2003·Nature Reviews. Drug Discovery·Han van de Waterbeemd, Eric Gifford
Apr 23, 2003·Trends in Pharmacological Sciences·Sean EkinsJ Andrew Williams
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thorir D BjornssonUNKNOWN FDA Center for Drug Evaluation and Research (CDER)
Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
Mar 19, 2004·Journal of Medicinal Chemistry·Richard A FriesnerPeter S Shenkin
Apr 15, 2004·Bioorganic & Medicinal Chemistry·Alex M Aronov, Brian B Goldman
Jul 1, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kenneth BachmannLidia Sambucetti
Nov 19, 2004·Drug Metabolism and Pharmacokinetics·Fumiyoshi Yamashita, Mitsuru Hashida
Jan 26, 2005·Journal of Chemical Information and Modeling·Gerhard Wolber, Thierry Langer
Feb 12, 2005·Molecular Endocrinology·Jill E ChrencikMatthew R Redinbo
Feb 18, 2005·Journal of Medicinal Chemistry·Sean E O'Brien, Marcel J de Groot
Apr 15, 2005·Journal of Medicinal Chemistry·Chris de GraafK Anton Feenstra
Apr 23, 2005·Pharmaceutical Research·Sean EkinsPeter W Swaan
Aug 2, 2005·Journal of Pharmacological and Toxicological Methods·Sean Ekins
Oct 15, 2005·Nature Reviews. Drug Discovery·Larry C Wienkers, Timothy G Heath
Jul 13, 2006·Biochemistry·Schroeder M NobleMatthew R Redinbo
Jul 19, 2006·Drug Discovery Today·Igor V TetkoGennadiy I Poda
Sep 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cheng ChangSean Ekins
Oct 20, 2006·Journal of Computer-aided Molecular Design·Nicola J RichmondRobert D Clark
Dec 13, 2006·Journal of Medicinal Chemistry·Alex M Aronov

❮ Previous
Next ❯

Citations

May 26, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Rachumallu RamakrishnaRabi Sankar Bhatta
Aug 28, 2016·Drug Discovery Today·Diana Gaspar, Dimitrios I Zeugolis
Nov 4, 2016·Expert Opinion on Drug Discovery·Kam Lun Hon, Vivian W Y Lee
Nov 6, 2018·Journal of Evidence-based Integrative Medicine·Regina Appiah-OpongAlexander K Nyarko
Jan 25, 2019·Current Topics in Medicinal Chemistry·Alexander V DmitrievVladimir V Poroikov
Mar 3, 2017·BMC Bioinformatics·Pathima Nusrath HameedSaman Halgamuge
Sep 5, 2019·Current Pharmaceutical Design·Harekrishna Roy, Sisir Nandi
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cristiana CorreiaNuno Vale
Aug 20, 2021·Basic & Clinical Pharmacology & Toxicology·Aleksi TornioJanne T Backman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.